CRMT
America's Car-Mart, Inc.
There isn't enough reported data to score CRMT yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CRMT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CRMT PE Valuation
CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
CRMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRMT to return to profit, with revenue declining.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over CRMT on the outlook, with more favorable revenue expectations.
CRMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q3 2026 | -$24.38 | -1462% |
| Q2 2026 | -$16.79 | -821% |
| Q1 2026 | -$11.15 | -1312% |
| Q4 2025 | -$1.53 | -$0.74 |
| Q3 2025 | $1.79 | +$7.49 |
| Q2 2025 | $2.33 | +$7.25 |
| Q1 2025 | $0.92 | +$5.60 |
| Q4 2024 | -$0.79 | +$2.32 |
CRMT has swung to a loss: it lost $24.38 per share over the past year, after a profit the year before.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over CRMT on earnings, with more consistent year-over-year improvement.
CRMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $145.8M | -57% |
| Q2 2026 | $302.8M | -18% |
| Q1 2026 | $286.8M | -12% |
| Q4 2025 | $350.2M | +0.8% |
| Q3 2025 | $341.3M | -1.9% |
| Q2 2025 | $370.2M | +1.5% |
| Q1 2025 | $325.7M | +8.7% |
| Q4 2024 | $347.3M | -4% |
CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | -45 points |
| Q2 2026 | -12% | -15 points |
| Q1 2026 | -13% | -14 points |
| Q4 2025 | -7.8% | -9.9 points |
| Q3 2025 | -2.2% | -1.8 points |
| Q2 2025 | 3.4% | +3.2 points |
| Q1 2025 | 1.4% | +4.8 points |
| Q4 2024 | 2% | +12 points |
CRMT's operating margin was −47% last quarter, down 45 points from the same quarter a year ago, near the bottom of its range since 2019.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over CRMT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN has the edge over CRMT on profitability, with a higher operating margin.
CRMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80M | +$86.4M |
| Q2 2026 | $67.4M | +266% |
| Q1 2026 | -$6.2M | +$25.3M |
| Q4 2025 | $8.3M | +$31.9M |
| Q3 2025 | -$6.4M | +$9.6M |
| Q2 2025 | $18.4M | +$30.4M |
| Q1 2025 | -$31.5M | -408% |
| Q4 2024 | -$23.6M | +$7.9M |
CRMT has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
CRMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +40.2K shares |
| 1 year | +0.7% | +55.5K shares |
| 3 years | +26% | +1.7M shares |
| 5 years | +19% | +1.3M shares |
| Available history | +20% | +1.4M shares |
CRMT has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25,000 |
| Q2 2026 | $2,000 |
| Q1 2026 | $23,000 |
| Q4 2025 | $205,000 |
| Q3 2025 | $71,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $20,000 |
| Q4 2024 | $388,000 |
CRMT spent $255,000 buying back its own shares over the past year, down 47% from the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CRMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2023 | -0.3x | Net Cash |
| Q2 2023 | 5.1x | High |
| Q4 2022 | 3.5x | Elevated |
| Q3 2022 | 1.7x | Healthy |
CRMT has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 18.7 | Oversold |
CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
CRMT PE vs Consumer Cyclical Sector
| Metric | CRMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CRMT has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
CRMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.09 | 15% below |
| 20 week MA | $2.09 | 56% below |
| 50 week MA | $11.0 | 92% below |
| 100 week MA | $27.0 | 97% below |
| 200 week MA | $49.6 | 98% below |
CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
CRMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.6 | $110.0 | +1.3% |
| 2021 | $110.0 | $102.8 | -6.5% |
| 2022 | $102.8 | $72.1 | -30% |
| 2023 | $72.1 | $75.8 | +5.1% |
| 2024 | $75.8 | $52.3 | -31% |
| 2025 | $52.3 | $25.9 | -51% |
| 2026 YTD | $25.9 | $0.93 | -96% |
CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over CRMT on returns for 2026, with the stronger performance.